BioCentury
ARTICLE | Company News

Hydra, Boehringer in CNS deal

April 25, 2014 12:28 AM UTC

Hydra Biosciences Inc. (Cambridge, Mass.) partnered with Boehringer Ingelheim GmbH (Ingelheim, Germany) to develop small molecule inhibitors against transient receptor potential cation channel subfami...